13F-HR filed by Lexington Partners L.P.
Lexington Partners L.P. filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-12, with 7 holding rows worth $193,598,000.
- Accession
- 0000950123-22-008846
- Filer
- CIK 1621157
- Filed
- 2022-08-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2022
A combination report, 7 entries on the cover page, a total value of $193,598,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $193,599,000 with VALUE read as thousands by filing date, 13F file number 028-17321. The quarter's positions are built on this report. The resolved quarter.
Other managers
- reports for this filerFRANKLIN RESOURCES INC 028-00734
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| KEURIG DR PEPPER INC COM | 49271V100 | Stock | 3,001,248 | $106,214,000 | thousands by filing date | |
| DUN & BRADSTREET HLDGS INC | 26484T106 | COM | 2,679,211 | $40,269,000 | thousands by filing date | |
| KRISPY KREME INC | 50101L106 | COMMON STOCK | 1,087,353 | $14,788,000 | thousands by filing date | |
| SOLARWINDS CORP | 83417Q204 | COM NEW | 1,239,867 | $12,709,000 | thousands by filing date | |
| N-ABLE INC COMMON STOCK | 62878D100 | Stock | 1,239,867 | $11,159,000 | thousands by filing date | |
| COMPASS INC | 20464U100 | CL A | 1,951,155 | $7,044,000 | thousands by filing date | |
| NGM BIOPHARMACEUTICALS INC | 62921N105 | COM | 110,428 | $1,416,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-22-008846 | this filing | 2022-08-12 | acceptance time not in the bulk data set |